News
From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...
Integrated pharmacokinetics (PK), exposure-response, safety, and efficacy data supported 6 mg/kg Q3W as the recommended Phase 2 dose (RP2D) of IBI343. This provides support for the conduct of ...
As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...
During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...
Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...
An AI-based EGFR biomarker tool could preclude the need for a rapid PCR test in nearly half of advanced lung adenocarcinoma cases, a study has suggested.
With EAGLE, lung cancer biopsy analysis is expedited, accurately predicting EGFR mutations and streamlining the diagnostic process for better patient outcomes.
I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...
The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results